|Bid||0.35 x 300|
|Ask||0.41 x 2200|
|Day's Range||0.36 - 0.38|
|52 Week Range||0.30 - 2.48|
|PE Ratio (TTM)||-0.51|
|Earnings Date||Aug 7, 2017 - Aug 11, 2017|
|Dividend & Yield||N/A (N/A)|
|1y Target Est||5.50|
NEW YORK , July 24, 2017 /PRNewswire/ -- Acacia Communications, Inc. (ACIA) Lifshitz & Miller announces investigation on behalf of ACIA investors concerning whether ACIA issued misleading statements about ...
Repros Therapeutics Inc. (RPRX) announced that its pipeline candidate Proellex which is being evaluated for uterine fibroids will remain on partial clinical hold.
Goldberg Law PC, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Repros Therapeutics Inc. .